INTRODUCTION
T lymphocytes are essential mediators of adaptive immunity. The T-cell receptor (TCR) controls T-cell activation through recognition of specific linear peptides presented by major histocompatibility complex (MHC) molecules [1] . It is understood that TCR function is constrained by three fundamental rules of T-cell biology: each lymphocyte bears a single receptor that imparts antigen specificity [2] , a TCR recognizes a specific linear peptide presented by MHC [3] , and TCRs are restricted to recognizing antigens presented by self-MHC as a consequence of thymic selection [4, 5] . However, studies over the past several decades have revealed that T cells do not always adhere to dogma. Alloreactivity, the ability of T cells to respond to allogeneic MHC, is a well established phenomenon with clinical implications for transplantation [6] . There is significant evidence for T-cell cross-reactivity [7] . And the existence of T cells expressing two TCRs with different specificities has been known for over 2 decades [8] .
The review will examine work investigating the development and function of dual TCR T cells. Recent studies have provided evidence for the necessity as well as deleterious consequences of dual TCR expression. The specific predisposition of dual TCR T cells for alloreactivity and the resulting contribution to pathology, specifically graft versus host disease (GVHD) following allogeneic hematopoietic stem cell transplantation (HSCT), will be reviewed. This review will highlight the unique opportunities presented for examining posttransplant immune responses and understanding fundamental T-cell biology through study of these cells.
Discovery of T cells expressing two receptors
Defining the rules of T cell antigen recognition provided a perspective that the identity of a T cell is inextricably tied to the antigen it recognizes. This view was complicated by description of dual specificity T-cell clones responding to allogeneic cells in vitro as well as to the immunizing antigen presented by autologous cells [9, 10] . This heterologous immunity suggested that these cells were either cross-reactive or expressed a second receptor imparting a secondary specificity. One such clone, A10, did indeed have two in-frame rearrangements of TCRa, along with a single in-frame TCRb rearrangement [11] . Both TCRa proteins were detected in the cell, providing potential for expression of two abTCR heterodimers. However, only a single abTCR enabled response to ovalbumin:I-A k and I-A s by transfected TCR-deficient T-cell hybrids, indicating that a singular cross-reactive TCR was responsible for both antigenic specificities of the clone. The presence of in-frame rearrangement of both TCRa loci was similarly observed in approximately onethird of peripheral T cells in other examinations of antigen-specific mouse T-cell clones [12] [13] [14] . Similar estimates have recently been provided using large-scale DNA sequencing approaches to examine human TCR repertoires [15 & ,16 & ]. These data provide evidence of the potential for coexpression of two TCRs by a single T cell, and suggest that allelic inclusion of TCRa is a physiologically normal process.
The first evidence for the functionality of naturally coexpressed TCRs came from examination of TCRVa expression on human peripheral blood lymphocytes [8] . Approximately 10 -3 -10 -4 peripheral blood T cells exhibited coincident labeling with two anti-TCRVa (TCRVa2, TCRVa12, or TCRVa24) monoclonal antibodies (mAbs). Based upon the frequencies of labeling with each of the TCRVa mAbs individually, it could be estimated that between 1 and 10% of human peripheral T cells expressed two TCRs on their surface. Critically, the functionality of both receptors on dual TCR clones was demonstrated by response to stimulation via mAbs against either TCR. Subsequent investigations in mice found similar frequencies of T cells expressing two TCRa chains on the cell surface [17, 18] , and revealed the existence of T cells expressing two TCRb chains, though at much lower frequencies (<1%) [19] [20] [21] . Together, these data provide evidence that the one cell, one receptor rule is not absolute, but instead that a small population of T cells expressing two functional TCRs exists under normal physiological conditions. Dual T-cell receptor T cells arise as a consequence of normal thymopoiesis T-cell development is a multistep process whereby hematopoietic progenitor cells respond to instructive cues directing their differentiation in the thymus [22] . The principle task for developing thymocytes is to generate a functional TCR that will enable them to be positively selected, avoid negative selection, and egress to the periphery [1] . This process ( Fig. 1 [23] [24] [25] . After functionality of the TCRb chain is ensured via b-selection, the thymocyte proliferates and progresses to the CD4 þ CD8 þ double-positive stage. Double-positive thymocytes recombine the TCRa V and J segments to produce a TCRa protein.
Functionality of the abTCR heterodimer is tested in double-positive thymocytes by the process of positive selection, which requires recognition of specific self-peptide: MHC (pMHC) ligands for promotion to CD4 þ or CD8 þ T cells. The kinetics of this process are not entirely defined, though it is known that a majority of double-positive thymocytes do not receive a positively selecting signal and die over a period of days [26] . Presumably to improve the efficiency of this process, TCRa gene rearrangement is not subject to the allelic exclusion observed for TCRb [27] . Both TCRa chromosomal loci are in an open, accessible state in double-positive thymocytes [28] , and RAG gene expression continues until the thymocyte receives a positively selecting signal [29] enabling iterative recombination [30, 31] . These mechanisms provide multiple chances for producing a TCRa capable of paring with the TCRb and mediating positive selection.
Consequences of TCR allelic inclusion were first evidenced in transgenic TCR systems. Although the presence of a transgenic TCRb results in few endogenous TCRb gene rearrangements, endogenous TCRa rearrangements are relatively common [23, 27, 32] , highlighting differences between TCRb
KEY POINTS
A small percentage of peripheral T cells expresses two abTCRs. Both of these receptors are functional and can mediate immune responses.
Dual TCR expression arises naturally as a consequence of simultaneous rearrangement of both TCRa loci which promotes efficient positive selection.
The TCR repertoire of dual TCR T cells has significantly increased frequencies of receptors recognizing allogeneic ligands. This translates to disproportionate contribution of dual TCR T cells to in-vitro and in-vivo alloreactive responses including GVHD.
and TCRa regulation. In the setting of transgenic TCRs and nonselecting MHC, endogenous TCR rearrangements are observed at increased frequencies and are required for development of mature T cells [30, [32] [33] [34] , demonstrating the importance of allelic inclusion. This also affects normal thymopoiesis, as thymocytes hemizygous for TCRa (TCRa Although TCRa allelic inclusion is beneficial for improving the efficiency of positive selection, it also presents a hazard by enabling escape of thymocytes bearing autoreactive TCRs from negative selection. Studies of transgenic autoreactive TCRs have demonstrated that the coexpression of endogenous secondary TCRa chains can result in downregulation of the transgenic TCR sufficient for escape from negative selection, but retaining functional autoreactivity in the periphery [33, [36] [37] [38] . Presumably this occurs because of competition for the fixed amount of CD3 components of the TCR complex [8] . A similar phenomenon was observed with incomplete TCRb allelic exclusion for the KRN transgenic TCR [39] .
Effects of secondary TCRs on selection of the overall TCR repertoire have been more difficult to define. TCRa þ/À mice retain capability to develop autoimmunity in models of experimental autoimmune encephalitis, lupus [40] , and collageninduced arthritis [41] , indicating that dual TCR T cells do not contain the entirety of the autoreactive repertoire. In contrast, the same study found that in nonobese diabetic mice challenged with cyclophosphamide, insulitis and diabetes were reduced by 74 and 100%, respectively in the absence of dual TCR T cells. This difference is noteworthy, as this model did not require administration of adjuvant, and suggests that the effect may relate to the underlying autoreactive T-cell repertoire. Recent examination of the naive dual TCR T-cell repertoire demonstrated that the absence of secondary TCRs in TCRa þ/À mice reduced the frequency of T cells ]. The autoimmune potential of secondary TCRs is underscored by a recent examination of a model of aerosolized ovalbumin-induced airway inflammation where the transgenic DO11.10 TCR-mediated thymic selection and responded to the immunogen, but endogenous TCRs were required for autoimmunity [42] . These results highlight the capability of naturally arising dual TCR T cells to contain unwanted reactivity that would otherwise be removed by negative selection (Fig. 2) .
Secondary T-cell receptors expand the antigenic repertoire of peripheral T cells
The most obvious evidence for secondary TCRs expanding the antigenic repertoire comes from transgenic TCR systems, where immunization with foreign antigens generates T-cell clones bearing the transgenic TCR responding to its antigen, as well as an endogenous TCR responding to the immunogen [33, 43, 44] . The pathogenic potential for heterologous immunity by dual TCR T cells was shown in system where the transgenic TCR recognizing MBP 79-87 :H2-K k was only capable of mediating encephalitis during viral infection after activation mediated by endogenous secondary TCRs responding to viral antigens [38] . At the repertoire level, the effects of dual TCR expression on antigenic recognition are more difficult to observe. 
Dual T-cell receptor T cells in alloreactivity
A contribution of secondary TCRs to pathologic alloreactivity was first evidenced by examining rejection of allogeneic skin grafts in F5 TCR transgenic mice (influenza NP 366 -374 :H2-D b ) [45] . T cells isolated from rejected grafts expressed endogenous TCRa and TCRb, which were necessary for rejection, as F5.RAG1
À/À T cells were not alloreactive. Expansion of the alloreactive repertoire in a naturally occurring dual TCR T cell was evidenced by the 2.102 T-cell clone [46] . The 2.102 clone contains two TCRa chains (Va2 and Va4) and a single TCRb (Vb1). The Va4Vb1 TCR mediates thymic selection, is reactive to a foreign protein hemoglobin [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] presented by self-MHC I-E k , and alloreactive to I-E p , whereas the secondary Va2Vb1 TCR does not mediate positive selection but enables alloreactivity to H-2 d [47] . Increased alloreactivity at the clonal level from expression of a secondary TCR is intuitive, as expression of a second receptor doubles the chances for FIGURE 2. Effects of secondary TCRs on thymic selection and repertoire formation. T cells expressing a single TCR rely on that TCR to mediate thymic selection. Positive selection ensures self-major histocompatibility complex restriction, whereas negative selection eliminates thymocytes bearing TCRs with unwanted autoreactive or highly cross-reactive specificities. Secondary TCRs can rely on the function of the primary TCR and are thus not subject to stringent thymic selection. This may have an important relationship with the atypical reactivity of dual TCR T cells in the periphery. TCR, T-cell receptor.
antigen recognition. As dual TCR T cells comprise only a small portion of the peripheral T-cell repertoire, it could be expected that they may only have a minor contribution to polyclonal alloreactive responses. However, genetic elimination of secondary TCRs reduced in-vitro alloreactive responses to MHC-mismatched cells by over 40% [47] . This disproportionate effect from the loss of the relatively small numbers of TCRs suggests that dual TCR T cells have an inherent predisposition for responding to allogeneic MHC. Indeed, the same study demonstrated a two-fold preferential expansion of dual TCR T cells by in-vitro allogeneic stimulation compared with nonspecific stimulation via anti-CD3 and anti-CD28 mAbs, and a similar effect was observed in human dual TCR T cells [48] . This selective effect of secondary TCRs on alloreactivity is underscored by subsequent studies demonstrating their disproportionate contribution to the naive Tcell repertoire recognizing specific allogeneic MHC ligands, but not foreign peptides presented by self-MHC [35 && ]. The effect of secondary TCRs on recognition of minor histocompatibility antigens (miHA) is less clear, as mixed results have been observed in mice and humans. Genetic elimination of secondary TCRs had no effect on the naive T-cell response to miHA Ea 52-68 :I-A b [35 && ], whereas human dual TCR T cells were found to respond to the miHA HA-1 H 137 -145 :HLA-A Ã 02 : 01 at frequencies 10-fold higher than unsorted peripheral blood T cells [48] . The reasons for the differences between these findings are unclear.
Importantly, alloreactivity imparted by secondary TCRs translates to a disproportionate contribution of dual TCR T cells to in-vivo pathologic alloreactive responses. Using a parent-to-F 1 MHCmismatched model of transplantation, dual TCR T cells were calculated to comprise as much as 75% of peripheral T cells in mice with severe acute GVHD, compared with 1-6% of T cells in control mice 4 weeks following syngeneic transplantation [47] . Expansion of dual TCR T cells begins with the earliest phases of GVHD, as wild-type T cells exhibit 170% of the proliferative capacity of TCRa þ/À T cells in the first 24 h after transfer to a MHC-mismatched recipient [35 && ]. Investigations in human HSCT patients demonstrated similar results. Dual TCR T cells were present in patients with symptomatic acute GVHD at frequencies 5.3-fold higher than in healthy controls, comprising 58.6 AE 6.4% of peripheral T cells [48] . In these patients, dual TCR T cells were activated and produced more IFN-g and IL-17a than single TCR T cells, demonstrating their pathogenic capability. This effect was dependent on donor T cells, and was more pronounced in patients receiving HLA-mismatched grafts. Dual TCR T cell expansion and activation was not observed in allogeneic HSCT patients not developing acute GVHD. Together these data demonstrate the patholo gic potential for dual TCR T cells to selectively and disproportionately influence pathologic alloreactivity.
CONCLUSION
The potential for dual TCR T cells to contain unwanted reactivity has been theorized since their discovery. Recent demonstration of the importance of TCRa allelic inclusion for efficient thymic selection indicates that secondary TCRa generation is a normal physiologic process. However, identification of the autoimmune and alloimmune potential of dual TCR T cells indicates a cost. Knowing this, the questions now become: what is the underlying mechanistic basis for the reactivity of dual TCR T cells, how do secondary TCRs affect the antigenic repertoire, and what are the consequences or opportunities related to clinical transplantation?
The most simplistic explanation for increased autoreactivity and alloreactivity by dual TCR T cells is that a second TCR provides a second opportunity for antigen recognition at the clonal level. Two important points of evidence suggest that this is not a sufficient explanation. First, dual TCR T cells are selectively overrepresented in alloreactive responses, a phenomenon not observed in responses to other antigens. Secondly, genetic elimination of secondary TCRa rearrangements in TCRa þ/À mice eliminates only a small fraction of the TCR repertoire, but results in dramatic and disproportionate reductions in alloreactivity without affecting responses to foreign antigens. It is likely that the ability of secondary TCRs to avoid negative selection, as evidenced in transgenic TCR systems, results in dual TCR T-cell clones containing autoreactive or highly cross-reactive TCRs that would otherwise be eliminated. Although the relationship between thymic selection and TCR reactivity in dual TCR T cells is undefined, preliminary efforts have demonstrated that secondary TCRs may contribute to flexibility in the recognition of allogeneic ligands; alloantigenspecific T cells from TCRa þ/À mice had no ability to recognize closely related altered peptide ligands in vitro, unlike wild-type alloantigen-specific T cells [35 && ]. This result is in line with evidence of the importance of negative selection in eliminating cross-reactive TCRs [49] , though more work is required to define this relationship.
Given the effects of secondary TCR expression in thymic selection, it is logical to question their effect on the peripheral T-cell repertoire. Instructive signals given to developing thymocytes through the TCR have important effects including CD4/CD8 lineage commitment, regulatory T cell (Treg) differentiation, and homeostatic capability [50] . Effects of secondary TCRs on these processes are not known, though it has been reported that human Tregs contain a three-fold higher proportion of dual TCR T cells [51] . It is not known whether these were thymically derived Tregs or cells peripherally converted to the Treg phenotype. However, this suggests that the increased reactivity of dual TCR T cells may make them effective regulators of immune responses.
Although the effects of dual TCR T cells in transplantation observed thus far have been deleterious, it is conceivable that their selective alloreactivity could be harnessed for development of novel therapies. The autoreactive and alloreactive potential of these cells may make them excellent candidates for cellular immunotherapies to enhance graft-versus-leukemia effects in HSCT. Conversely, evidence of dual TCR T cells as Tregs suggests that they may be amenable to strategies promoting allograft tolerance. Further study of dual TCR T cells will continue to define their role in normal physiology, revealing novel aspects of T-cell biology, and possibly provide new avenues for development of novel therapeutic approaches.
